Propanc Biopharma
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-46.79M-9.67M-0.00-0.00-0.00-0.02-0.06-0.07-0.07-0.06-0.19-0.02
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-52.29M-35.50M-0.00-0.00-0.00-0.02-0.05-0.08-0.07-0.02-0.16-0.02
Price/Cash Flow ratio
-111.94M-20.24M-0.00-0.00-0.00-0.05-0.13-0.17-0.21-0.11-0.32-0.05
Price/Free Cash Flow ratio
-111.64M-20.19M-0.00-0.00-0.00-0.05-0.13-0.17-0.21-0.11-0.32-0.05
Price/Earnings Growth ratio
-467.92KN/AN/A0.000.000.000.000.000.000.00-0.000.00
Dividend Yield
N/AN/AN/AN/AN/AN/A249.86%278.97%198.63%N/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
2.21%0.76%3.74%2.48%1.96%2.76%5.30%2.02%4.65%6.62%-0.01%2.76%
Return on Assets
-544.23%-2482.01%-8275.56%-9860.55%-5666.39%-4811.30%-18471.87%-4115.07%-5188.30%-2515.75%-2304.61%-5666.39%
Return On Equity
111.76%366.83%144.57%104.25%133.91%130.16%78.88%111.12%100.41%48.17%85.44%130.16%
Return on Capital Employed
55.85%268.87%105.48%58.64%60.79%95.95%59.07%66.77%57.35%41.28%79.11%60.79%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.01N/A
Quick Ratio
0.160.120.010.000.020.010.000.000.000.000.000.01
Cash ratio
0.020.040.010.000.000.010.000.000.000.000.000.00
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/A-70.74-0.02-56.36N/A-36.28N/AN/A-70.74
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
23.20K154.02K81.47K13.84K11.93K9.36K13.01K12.13K12.23K12.96KN/A9.36K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
2.903.3235.7166.5916.8116.3251.9111.978.3712.8327.9816.81
Debt Equity Ratio
-0.59-0.49-0.62-0.70-0.39-0.44-0.22-0.32-0.16-0.24-1.03-0.44
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/A-0.01-0.01N/A
Total Debt to Capitalization
-1.47-0.96-1.65-2.37-0.65-0.79-0.28-0.47-0.19-0.32-0.30-0.65
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-4.20N/A
Cash Flow to Debt Ratio
-0.78-3.57-0.60-0.45-1.20-1.14-1.68-1.46-2.18-1.00-2.12-1.14
Company Equity Multiplier
-0.20-0.14-0.01-0.01-0.02-0.02-0.00-0.02-0.01-0.01-0.03-0.02
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.00111.001111111
Cash Flow Coverage Ratio
-0.78-3.57-0.60-0.45-1.20-1.14-1.68-1.46-2.18-1.00-2.12-1.14
Short Term Coverage Ratio
-0.78-3.57-0.60-0.45-1.20-1.14-1.68-1.46-2.18-1.07-2.22-1.14
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A-16.18%-20.84%-14.89%N/AN/AN/A